Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Skin-derived stem cells grow faster and are easier to obtain than hair follicle stem cells, but both can become various cell types.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

FOXN1 gene variants cause low T cells and immune issues from birth.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.